The NIDDK has proposed a research program to establish and maintain the infrastructure for a Hepatotoxicity Clinical Research Network (HCRN). This network will comprise 4-5 Clinical Centers (CCs) and a Data Coordinating Center (DCC). The primary objective of the HCRN is to develop standardized instruments to identify and fully characterize bona fide cases of drug-, CAM- and toxin-induced liver injury. This will allow for an investigation of the full epidemiological and clinical spectrum of hepatotoxicity. Biological samples will be obtained for the study of the pathogenesis of hepatotoxicity using biochemical, serological and genetic techniques. This initiative will expand current understanding of the mechanisms of drug and toxin-induced liver injury and provide the basis for more effective and safer medical therapies. The Duke Clinical Research Institute (DCRI) proposes to serve as the Data Coordinating Center for this project. In this role, we will apply our considerable experience and resources to coordinate and facilitate the activities of this study and to ensure that scientifically defensible conclusions can be drawn. In particular, we will attend to the following functions: (1) Study Coordination: an efficient organizational structure will be established to ensure that activities advance in a coordinated fashion. (2) Site Management and Monitoring: we will develop a site management plan to safeguard the integrity of the accumulating data. (3) Data Management Activities: we will apply a comprehensive system for on-going data collection and generate reports summarizing progress in the conducting the study. (4) Statistical Analysis: we will provide statistical leadership in the design of these studies, and perform statistical analyses in an expeditious and timely manner.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01DK065176-05
Application #
7289257
Study Section
Special Emphasis Panel (ZDK1-GRB-3 (M1))
Program Officer
Serrano, Jose
Project Start
2003-09-30
Project End
2008-08-31
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
5
Fiscal Year
2007
Total Cost
$831,240
Indirect Cost
Name
Duke University
Department
Biostatistics & Other Math Sci
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Bonkovsky, Herbert L; Barnhart, Huiman X; Foureau, David M et al. (2018) Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group. PLoS One 13:e0206389
Dakhoul, Lara; Ghabril, Marwan; Gu, Jiezhun et al. (2018) Heavy Consumption of Alcohol is Not Associated With Worse Outcomes in Patients With Idiosyncratic Drug-induced Liver Injury Compared to Non-Drinkers. Clin Gastroenterol Hepatol 16:722-729.e2
Ahmad, Jawad; Rossi, Simona; Rodgers, Shuchi K et al. (2018) Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury. Clin Gastroenterol Hepatol :
Church, Rachel J; Kullak-Ublick, Gerd A; Aubrecht, Jiri et al. (2018) Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort. Hepatology :
Urban, Thomas Jacob; Nicoletti, Paola; Chalasani, Naga et al. (2017) Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B?35:02 as a risk factor. J Hepatol 67:137-144
Suzuki, Ayako; Barnhart, Huiman; Gu, Jiezhun et al. (2017) Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury. Liver Int 37:1723-1730
Whritenour, Jessica; Ko, Mira; Zong, Qing et al. (2017) Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response. J Immunotoxicol 14:31-38
Björnsson, Einar S; Gu, Jiezhun; Kleiner, David E et al. (2017) Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes. J Clin Gastroenterol 51:63-69
de Boer, Ynto S; Kosinski, Andrzej S; Urban, Thomas J et al. (2017) Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clin Gastroenterol Hepatol 15:103-112.e2
Chalasani, Naga; Reddy, K Rajender K; Fontana, Robert J et al. (2017) Idiosyncratic Drug Induced Liver Injury in African-Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians. Am J Gastroenterol 112:1382-1388

Showing the most recent 10 out of 63 publications